期刊文献+

肠道微生物与卵巢癌关系的研究进展 被引量:4

Advancement in relationship between intestinal microflora and ovarian cancer
下载PDF
导出
摘要 卵巢癌是女性生殖器常见的恶性肿瘤之一,因其早期症状不典型,发现时多已发生子宫、对侧附件、大网膜、肠管和盆腔器官转移,且恶化迅速,极易复发,故治疗效果和预后都很差。近年来研究发现,一直以来被认为是无菌的女性上生殖道其实是含有细菌的,而且在卵巢癌女性上生殖道中发现了致病性较强的细菌种类。一个正常成人体内,肠道内微生物的总质量可达1~1. 5 kg,包含的数量可达1 014个,它们相互协调共同导致盆腔各器官慢性炎症的发生,并影响全身各系统疾病的进展。本文就肠道微生物对卵巢癌的发生、发展和治疗的影响进行讨论,总结及初步探讨肠道微生物与卵巢癌的关系及调节肠道微生物稳态在卵巢癌预防和治疗中的应用。 Ovarian cancer is a common malignant tumor of female genital mutilation,because of its early symptoms is not typical,and it was found until the uterus,the contralateral accessoried,greater omentum,bowel and pelvic organ metastasis,and deterioration is rapid,easy to relapse,so the treatment effect and prognosis is poor.In recent years,studies have found that the upper reproductive tract of women who have long been considered sterile actually contains bacteria,and that more pathogenic bacteria have been found in the upper reproductive tract of women with ovarian cancer.A normal adults,in the gut microbial total quality can reach 1~1.5 kg,contain up to 1 014,the number of them coordinate with each other together lead to chronic inflammation,pelvic organs and affect the whole body each system disease progression.In this paper,the gut microbes in ovarian cancer occurrence,development and treatment are discussed,the influence of summarizes and discusses the relationship between gut microbes and ovarian cancer and further adjust the gut microbes steady state in the application of the prevention and treatment of ovarian cancer.
作者 俞亚媛 熊艺菲 谭布珍 YU Ya-Yuan;XIONG Yi-Fei;TAN Bu-Zhen(Second Affiliated Hospital of Nanchang University,Nanchang 330006,China)
出处 《中国免疫学杂志》 CAS CSCD 北大核心 2018年第9期1437-1441,共5页 Chinese Journal of Immunology
关键词 肠道微生物 卵巢癌 雌激素 恶病质 Gut microbes Ovarian cancer Estrogen Cachexia
  • 相关文献

参考文献3

二级参考文献30

  • 1Jones MB.Borderline ovarian tumors;current concepts for prognostic factors and clinical management[J].Clin Obstet Gynecol,2006,49(3):517-525.
  • 2Link CJ Jr,Kohn E,Reed E.The relationship between borderlineovarian tumors and epithelial ovarian carcinoma;epidemiologic,pathologic,and molecular aspects[J].Gynecol Oncol,1996,60(3):347-354.
  • 3Pium B,Rabinovich A,Yanai-Inbar 1.Three primary malignancies related to BRCA mutation successively occurring in a BRCAI 185delAG mutation tamer[J].Eur J Obstet Gynecol Reprod Biol,2001,97(2):241-244.
  • 4Helou K,Padilla-Hash H,Wangsa D,et al.Comparative genome hybridization reveals specific genomic imbalances during the genesis from benign through borderline to malignant ovarian tumors[J].Cancer Genet Cytogenet,2006,170(1):1-8.
  • 5Gotlieb WH,Chetrit A,Menczer J,et al.Demographic and genetic characteristics of patients with borderline ovarian tumors as compared to early stage invasive ovarian cancer[J].Gynecol Oncot,2005,97(3):780-783.
  • 6Sijmons EA,van Lankveld MA,Witteveen PO,et al.Compliance to clinical guidelines for early-stage epithelial ovarian cancer in relation to patient outcome[J].Eur J Obstet Gynecol Reprod Biol,2007,131(2):203-208.
  • 7Tempfer CB,Poltersuer S,Bentz EK,et al.Accuracy of intraoperative frozen section analysis in borderline tumors of the ovary:A retrospective analysis of 96 cases and review of the literature[J].Gynecol Oncol,2007,107(2):248-252.
  • 8Kim K,Chung HH,Kim JW,et al.Clinical impact of under-diagnosis by frozen section examination is minimal in borderline ovarian tumors,.Eur J Sorg Oncol,2009,35(9):969-973.
  • 9Webb PM,Purdie DM,Graver S,et al.Symptoms and diagnosis of borderline,early and advanced epithelial ovarian cancer[J] Gynecol Oncol,2004,92(l):232-239.
  • 10Gershenson DM.Clinical management potential tumors of low malignancy[J].Best Pract Res Clin Obstet Gynaeeol,2002,16(4):513-527.

共引文献36

同被引文献35

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部